Skip to main content

Month: August 2020

Harsco Corporation Appoints Wendy Livingston as Senior Vice President, Human Resources and Chief Human Resources Officer

CAMP HILL, Pa., Aug. 18, 2020 (GLOBE NEWSWIRE) — Harsco Corporation (NYSE: HSC) today announced it has appointed Wendy Livingston as Senior Vice President, Human Resources and Chief Human Resources Officer (CHRO).In this role, Livingston will be responsible for developing the human resources global strategy for the Company and its 13,000 employees located in more than 30 countries. She will work alongside corporate functional heads and division presidents on driving performance, teamwork and people development to achieve Harsco’s financial objectives and long-term business plan.Livingston joins Harsco from The Boeing Company (NYSE: BA) where she worked for the past 24 years, most recently as Vice President, Corporate Human Resources. In this capacity, she supported the corporate business unit comprised of 30,000 employees. Livingston...

Continue reading

Spackman Equities Group Inc. Enters Into Non-Binding Memorandum of Understanding With Spackman Entertainment Group to Acquire Shares of Spackman Media Group

Spackman Equities Group Inc. (the “Company” or “SQG”) has entered into a non-binding memorandum of understanding (“MOU”) with Spackman Entertainment Group Limited, a company listed on the Catalist Board of the Singapore Stock Exchange, to acquire Spackman Entertainment Group’s entire interest in Spackman Media Group Limited (“Proposed Acquisition”)Under the MOU, the Company will acquire all of Spackman Entertainment Group’s 13,968,038 common voting shares of Spackman Media Group, representing a 43.88% interest in Spackman Media Group Limited, to be fully paid by newly issued common shares of the CompanyUpon completion of the Proposed Acquisition, the Company and Spackman Entertainment Group plan to develop, produce and finance motion pictures and entertainment content targeted for the North American market, as well as develop other entertainment-related...

Continue reading

Hill International to Support Key Development on Bosnia and Herzegovina’s Principal Motorway

PHILADELPHIA and SARAJEVO, Bosnia and Herzegovina, Aug. 18, 2020 (GLOBE NEWSWIRE) — Hill International (NYSE:HIL) (Hill), the global leader in managing construction risk, announced today it has been selected by JP Autoceste FBiH to provide technical assistance to the Project Implementation Unit (PIU) for the construction of an approximately 5.5 KM motorway between Poprikuše and Nemila in the Mediterranean Core Network (Corridor Vc).The Corridor Vc project represents a €188.3 million investment by the European Bank for Reconstruction and Development and the European Investment Bank. Given the challenging geotechnical properties of the region, the new motorway will feature several unique elements, such as the 3.6 KM Golubinja tunnel, two bridges, two viaducts, an overpass, and a roundabout.The project is also a key part of the national...

Continue reading

DigitalAMN Finalizes Onboarding of Mail-In Ballot Specialist, Global Election Services Inc.

NEW YORK, Aug. 18, 2020 (GLOBE NEWSWIRE) — Digital Asset Monetary Network, Inc. or “DigitalAMN” (OTCMKTS: DATI), a Public Accelerator-Incubator (“PAI”), announced today, that management has finalized its agreement with Global Election Services, Inc. (“GES”), completing the onboarding of the mail ballot and In-Person election specialist, which provides comprehensive technology-enabled election services to organizations such as labor unions, pension funds, credit unions, colleges, universities, co-operatives, housing organizations, trade associations, political parties, associations, professional societies, and entertainment organizations.“During our business selection process, we look to align with companies that complement our mantra: ‘Do Good, While Doing Well’,” stated Ajene Watson, CEO of DigitalAMN. “Vote By Mail is undoubtedly...

Continue reading

Ceapro Inc. Provides Update on Development of an Inhalable Therapeutic for COVID-19

– First milestone successfully achieved in early stages of the ongoing research project with McMaster University– Confirmed capability of PGX Technology to optimize and standardize the size and morphology of yeast beta-glucan (PGX-YBG) suitable for lung inhalation– In-vitro study with human cell lines demonstrated that PGX-YBG obtained from different sources exhibited significant stimulatory effect on human immune response EDMONTON, Alberta, Aug. 18, 2020 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today provided an update on its ongoing collaboration with McMaster University to develop an inhalable therapeutic for COVID-19.The project, entitled...

Continue reading

Microchip Announces High-Speed CoaXPress® 2.0 Devices that Speed Machine Vision Image Capture While Simplifying System Design and Deployment

Builds on company’s work with industry standards bodies and lead customers who are using the devices to create capture cards and cameras supporting the new specificationsCHANDLER, Ariz., Aug. 18, 2020 (GLOBE NEWSWIRE) — Until the 12.5Gbps CoaXPress® 2.0 interface standard was ratified last year, machine-vision image-capture solutions had replaced conveyor belts as the primary roadblock to achieving faster production-line throughput. Now, Microchip Technology Inc. (Nasdaq: MCHP) has taken the next step toward realizing the full potential of CoaXPress (CXP) on the factory floor with the first single-chip physical-layer interface devices to include features that streamline machine vision system design, maximize transmission speed and simplify deployment in high-volume bottling operations, food inspection, industrial inspection and...

Continue reading

Electric Vehicle Charging Stations Market Growing at an Impressive 23.24% CAGR between 2020 and 2027; Increasing Government Fund to Develop Charging Infrastructure will Spur Demand: Fortune Business Insights™

Pune, Aug. 18, 2020 (GLOBE NEWSWIRE) — The global electric vehicle charging stations market size is expected to showcase a significant growth by reaching USD 100.96 billion by 2027, while exhibiting an astounding CAGR of 23.24% between 2020 and 2027. This is attributable to the increasing government fund to develop electric charging infrastructure and the growing demand for electrification of vehicles across the globe. This information is published by Fortune Business Insights, in its latest report, titled, “Electric Vehicle Charging Stations Market Size, Share & COVID-19 Impact Analysis, By Charger Type (Fast, Slow/Moderate), By Application (Commercial, Residential) and Regional Forecasts, 2020-2027.” The report further mentions that the market was worth USD 39.70 billion in 2019.Complete Shutdown amid COVID-19 to Lead to...

Continue reading

Trinity Biotech plc to Announce Second Quarter 2020 Financial Results

DUBLIN, Ireland, Aug. 18, 2020 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter 2020 on Tuesday, August 25, 2020. The Company has scheduled a conference call for that same day, Tuesday, August 25, 2020 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.A simultaneous webcast of the call can be accessed at:https://services.choruscall.com/links/trib200819.htmlTo access the replay using an international dial-in number, please see the link below:https://services.choruscall.com/ccforms/replay.htmlA webcast of the call will be available until August 25, 2021:https://services.choruscall.com/links/trib200819.htmlReplays will be available 1 hour after the...

Continue reading

Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce Agreement to Make Firdapse® (amifampridine phosphate) Available to LEMS Patients in Canada

CORAL GABLES, Fla., Aug. 18, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, and KYE Pharmaceuticals Inc. (“KYE”), a private company headquartered in Mississauga, Ontario and focused on bringing medicines that fulfill clinically significant unmet needs to the Canadian market, today announced that the companies have entered into an exclusive license agreement under which KYE will commercialize Firdapse® in Canada. Firdapse® is indicated for the symptomatic treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. Under the terms of the agreement, Catalyst will supply Firdapse® to KYE and KYE...

Continue reading

XBiotech étudie une piste thérapeutique contre le COVID-19

AUSTIN, Texas, 18 août 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd’hui avoir identifié des anticorps True Human pouvant potentiellement être utilisés comme traitement contre le SARS-CoV2, le virus responsable du COVID-19. La société a découvert ces anticorps dans le cadre d’une collaboration avec BioBridge Global, société mère du South Texas Blood & Tissue Center et de QualTex Laboratories, l’un des plus grands laboratoires d’essais indépendant aux États-Unis.Pour cette collaboration, BioBridge Global a utilisé la technologie brevetée de dépistage du COVID-19 de XBiotech pour identifier des donneurs de sang ayant été infectés par le nouveau coronavirus, dans le cadre d’un programme qui vise à fournir un plasma en phase de convalescence pour traiter les patients ayant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.